Bruce C. Cozadd is CEO & Chairman at Jazz Pharmaceuticals plc (JAZZ). They have made 66 open-market trades across 2 companies since 2010, most recently 2026-09-01.
CIK 0001193210
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $86K since 2010, against 65 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 351,875 | $73.9M |
| CERS | 18,921 | $41K |
| Total | $74.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL · 10b5-1 | 2026-09-01 | 2026-09-02 | $250.13 | $1.5M | -2.7% | -4.8% | — |
| JAZZ | SELL · 10b5-1 | 2026-08-03 | 2026-08-05 | $252.98 | $1.5M | -5.5% | -6.1% | — |
| JAZZ | SELL · 10b5-1 | 2026-07-01 | 2026-07-06 | $240.47 | $1.4M | +1.0% | +9.2% | -1.5% |
| JAZZ | SELL · 10b5-1 | 2026-06-01 | 2026-06-03 | $235.12 | $1.4M | -2.3% | +3.5% | +3.3% |
| JAZZ | SELL · 10b5-1 | 2026-05-01 | 2026-05-05 | $203.33 | $1.2M | +0.7% | +5.7% | +11.1% |
| JAZZ | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $190.50 | $1.1M | +6.6% | +11.3% | +30.2% |
| JAZZ | SELL · 10b5-1 | 2026-03-03 | 2026-03-04 | $186.44 | $1.1M | -2.7% | -0.1% | +20.9% |
| JAZZ | SELL | 2025-11-26 | 2025-12-01 | $177.81 | $27.6M | -4.7% | -1.8% | +10.0% |
| JAZZ | SELL | 2025-11-18 | 2025-11-20 | $181.09 | $6.5M | -4.8% | -3.4% | -3.9% |
| JAZZ | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $137.01 | $754K | -1.7% | +0.2% | +25.4% |
| JAZZ | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $128.62 | $772K | -1.0% | +7.6% | +30.7% |
| JAZZ | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $113.21 | $113K | +9.5% | +19.0% | +28.7% |
| JAZZ | SELL · 10b5-1 | 2025-07-01 | 2025-07-03 | $107.63 | $108K | +6.8% | +6.9% | +26.0% |
| JAZZ | SELL · 10b5-1 | 2025-06-02 | 2025-06-04 | $108.95 | $109K | -0.2% | -2.1% | +18.0% |
| JAZZ | SELL · 10b5-1 | 2025-05-01 | 2025-05-05 | $117.57 | $176K | -9.7% | -6.9% | -1.2% |
| JAZZ | SELL · 10b5-1 | 2025-04-01 | 2025-04-03 | $123.75 | $186K | -11.7% | +1.5% | -5.6% |
| JAZZ | SELL · 10b5-1 | 2025-03-03 | 2025-03-03 | $144.25 | $938K | -2.4% | -9.3% | -22.3% |
| JAZZ | SELL · 10b5-1 | 2025-02-03 | 2025-02-05 | $122.31 | $183K | +11.0% | +13.8% | -8.9% |
| JAZZ | SELL | 2025-01-02 | 2025-01-06 | $123.43 | $185K | -0.6% | -0.3% | -12.3% |
| JAZZ | SELL · 10b5-1 | 2024-12-02 | 2024-12-04 | $121.17 | $242K | +2.0% | -1.7% | +13.3% |
| JAZZ | SELL | 2024-11-01 | 2024-11-05 | $110.84 | $111K | +7.6% | +8.9% | +7.9% |
| JAZZ | SELL | 2023-02-01 | 2023-02-03 | $155.79 | $156K | -4.2% | -8.5% | -12.2% |
| JAZZ | SELL | 2023-01-03 | 2023-01-05 | $159.86 | $480K | -3.2% | -4.3% | -8.9% |
| JAZZ | SELL | 2022-12-01 | 2022-12-05 | $157.00 | $157K | +1.6% | +6.5% | -5.2% |
| JAZZ | SELL | 2022-11-10 | 2022-11-14 | $150.00 | $300K | +2.1% | +5.1% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.